Occudo Quantitative Strategies LP Artivion, Inc. Transaction History

Occudo Quantitative Strategies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.62 - $25.65 $24,289 - $31,754	-1,238 Reduced 10.97%	10,047 $257,000
Q1 2024 May 15, 2024	SELL	$16.7 - $21.63 $47,294 - $61,256	-2,832 Reduced 20.06%	11,285 $238,000
Q4 2023 Feb 14, 2024	BUY	$12.33 - $18.83 $174,062 - $265,823	14,117 New	14,117 $252,000
Q1 2023 May 15, 2023	SELL	$11.74 - $14.12 $38,577 - $46,398	-3,286 Reduced 19.93%	13,198 $172,000
Q4 2022 Feb 14, 2023	BUY	$10.01 - $13.9 $60,940 - $84,623	6,088 Added 58.56%	16,484 $199,000
Q3 2022 Nov 14, 2022	BUY	$13.31 - $23.25 $138,370 - $241,707	10,396 New	10,396 $144,000
Q2 2022 Aug 15, 2022	SELL	$15.73 - $22.91 $147,673 - $215,079	-9,388 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$16.95 - $21.74 $159,126 - $204,095	9,388 New	9,388 $201,000
Q4 2021 Feb 14, 2022	SELL	$17.19 - $22.84 $162,926 - $216,477	-9,478 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.29 - $28.7 $211,264 - $272,018	9,478 New	9,478 $211,000

173

35.8M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.27B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.